the purpose of this study was to evaluate vap combination chemotherapy in advanced breast cancer : prednimustine 80 mg/m2 p.o . days 1-5 , adriamycin 40 mg/m2 and vincristine 1.4 mg/m2 1st day in cycles of 3 weeks .
C0078039
vap combination chemotherapy
C0042679
vincristine